MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 108 filers reported holding MYOVANT SCIENCES LTD in Q1 2021. The put-call ratio across all filers is 5.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,515,152 | +133.8% | 56,200 | +55.8% | 0.00% | +200.0% |
| Q3 2022 | $648,000 | -91.8% | 36,083 | -94.3% | 0.00% | -93.8% |
| Q2 2022 | $7,872,000 | +832.7% | 633,305 | +1068.6% | 0.02% | +700.0% |
| Q4 2021 | $844,000 | +43.5% | 54,193 | +109.9% | 0.00% | -33.3% |
| Q2 2021 | $588,000 | +147.1% | 25,814 | +199.1% | 0.00% | +200.0% |
| Q4 2020 | $238,000 | -93.0% | 8,630 | -94.8% | 0.00% | -95.8% |
| Q2 2020 | $3,422,000 | +1067.9% | 165,934 | +328.1% | 0.02% | +700.0% |
| Q1 2020 | $293,000 | -19.7% | 38,759 | -44.8% | 0.00% | 0.0% |
| Q3 2019 | $365,000 | – | 70,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |